BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 11775923)

  • 1. [Clinical analysis of 96 cases with pulmonary disease caused by nontuberculous mycobacteria].
    Xia X; Gui X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Apr; 22(4):239-41. PubMed ID: 11775923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008.
    Wang HX; Yue J; Han M; Yang JH; Gao RL; Jing LJ; Yang SS; Zhao YL
    Chin Med J (Engl); 2010 Jan; 123(2):184-7. PubMed ID: 20137367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary mycobacterioses--frequency of occurrence, clinical spectrum and predisposing factors].
    Czajkowska M; Augustynowicz-Kopeć E; Zwolska Z; Bestry I; Martusewicz-Boros M; Marzinek M; Radzikowska E; Remiszewski P; Roszkowska-Sliz B; Szopiński J; Załeska J; Zych J; Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 2002; 70(11-12):550-60. PubMed ID: 12884564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and radiological features of Mycobacterium kansasii and other NTM infections.
    Matveychuk A; Fuks L; Priess R; Hahim I; Shitrit D
    Respir Med; 2012 Oct; 106(10):1472-7. PubMed ID: 22850110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and radiographic manifestations of uncommon pulmonary nontuberculous mycobacterial disease in AIDS patients.
    El-Solh AA; Nopper J; Abdul-Khoudoud MR; Sherif SM; Aquilina AT; Grant BJ
    Chest; 1998 Jul; 114(1):138-45. PubMed ID: 9674460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology.
    Corbett EL; Hay M; Churchyard GJ; Herselman P; Clayton T; Williams BG; Hayes R; Mulder D; De Cock KM
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):501-7. PubMed ID: 10383063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lung diseases due to opportunistic environmental Mycobacteria in patients uninfected with human immunodeficiency virus. Risk factors, clinical and diagnostic aspects and course].
    Martínez Moragón E; Menéndez R; Santos M; Lorente R; Marco V
    Arch Bronconeumol; 1996 Apr; 32(4):170-5. PubMed ID: 8689013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobacteria: a retrospective cohort study.
    Gommans EP; Even P; Linssen CF; van Dessel H; van Haren E; de Vries GJ; Dingemans AM; Kotz D; Rohde GG
    Respir Med; 2015 Jan; 109(1):137-45. PubMed ID: 25464905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London.
    Davies BS; Roberts CH; Kaul S; Klein JL; Milburn HJ
    Scand J Infect Dis; 2012 Nov; 44(11):815-9. PubMed ID: 23078529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
    Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
    Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.
    Morimoto K; Hasegawa N; Izumi K; Namkoong H; Uchimura K; Yoshiyama T; Hoshino Y; Kurashima A; Sokunaga J; Shibuya S; Shimojima M; Ato M; Mitarai S
    Ann Am Thorac Soc; 2017 Jan; 14(1):49-56. PubMed ID: 27788025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features of pulmonary disease caused by Mycobacterium fortuitum].
    Hagiwara E; Sekine A; Sato T; Baba T; Shinohara T; Endo T; Sogo Y; Nishihira R; Komatsu S; Matsumoto Y; Ogura T; Takahashi H
    Nihon Kokyuki Gakkai Zasshi; 2008 Oct; 46(10):788-92. PubMed ID: 19044027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
    Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
    Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.
    Rawson TM; Abbara A; Kranzer K; Ritchie A; Milburn J; Brown T; Adeboyeku D; Buckley J; Davidson RN; Berry M; Kon OM; John L
    Respir Med; 2016 Nov; 120():101-108. PubMed ID: 27817806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria.
    Vera-Cabrera L; Brown-Elliott BA; Wallace RJ; Ocampo-Candiani J; Welsh O; Choi SH; Molina-Torres CA
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4027-9. PubMed ID: 17015632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China.
    Zhang Z; Pang Y; Wang Y; Cohen C; Zhao Y; Liu C
    Int J Antimicrob Agents; 2015 May; 45(5):491-5. PubMed ID: 25795316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011.
    de Mello KG; Mello FC; Borga L; Rolla V; Duarte RS; Sampaio EP; Holland SM; Prevots DR; Dalcolmo MP
    Emerg Infect Dis; 2013 Mar; 19(3):393-9. PubMed ID: 23745217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the MALDI-TOF MS method to identify nontuberculous mycobacteria.
    Kodana M; Tarumoto N; Kawamura T; Saito T; Ohno H; Maesaki S; Ikebuchi K
    J Infect Chemother; 2016 Jan; 22(1):32-5. PubMed ID: 26603481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of nontuberculous mycobacteria in treated patients with pulmonary disease in Greece - relation to microbiological data.
    Manika K; Tsikrika S; Tsaroucha E; Karabela S; Karachaliou I; Bosmi I; Kioumis I; Papavasileiou A
    Future Microbiol; 2015; 10(8):1301-6. PubMed ID: 26226382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
    Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.